Filing Details
- Accession Number:
- 0001104659-18-002870
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-18 16:36:25
- Reporting Period:
- 2018-01-16
- Accepted Time:
- 2018-01-18 16:36:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613859 | Pra Health Sciences Inc. | PRAH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181151 | Linda Baddour | C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612 | Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-16 | 67,000 | $11.73 | 67,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 64,405 | $90.26 | 2,595 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-16 | 2,595 | $90.56 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-16 | 39,374 | $0.00 | 39,374 | $11.73 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-16 | 27,626 | $0.00 | 27,626 | $11.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,931 | 2023-12-20 | No | 4 | M | Direct | |
| 117,669 | 2023-12-20 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $89.54 to $90.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.54 to $90.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The options vested on September 23, 2017.
- The options vested on March 2, 2016 upon satisfaction of certain performance criteria.
Billionaire Hedge Funds
